Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Parvez Khan

Showing results (41-50 of 128) with videos related to

Pageof 13
Sort By:
Contemporary Clinical Trials|January 10, 2023
Gender differences in first authorship of randomized controlled trials from IndiaBharat Rawlley, Afzal Parvez Khan, Shrey Chopra, et al.
Annals of African Medicine|November 29, 2025
Comparison of Ultrasound-assisted versus Landmark-guided Subarachnoid Block in Patients of Ankylosing Spondylitis Undergoing Total Hip Replacement: A Prospective Randomized TrialNeel Kamal Mishra, Rishabh Mishra, Prem Raj Singh, et al.
Molecular and Cellular Biochemistry|July 27, 2017
Evidence of vanillin binding to CAMKIV explains the anti-cancer mechanism in human hepatic carcinoma and neuroblastoma cellsHuma Naz, Mohd Tarique, Parvez Khan, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|July 29, 2019
Evaluation of ellagic acid as an inhibitor of sphingosine kinase 1: A targeted approach towards anticancer therapyPreeti Gupta, Taj Mohammad, Parvez Khan, et al.
Bone|July 19, 2016
Characterization of BMP signaling dependent osteogenesis using a BMP depletable avianized bone marrow stromal cell line (TVA-BMSC)Prem Swaroop Yadav, Mohd Parvez Khan, Paritosh Prashar, et al.
Molecular Pharmaceutics|July 25, 2018
Thienopyrimidine-Chalcone Hybrid Molecules Inhibit Fas-Activated Serine/Threonine Kinase: An Approach To Ameliorate Antiproliferation in Human Breast Cancer CellsNashrah Sharif Khan, Parvez Khan, Mohammad Fawad Ansari, et al.
International Journal of Biological Macromolecules|July 25, 2022
Structure-guided design and development of cyclin-dependent kinase 4/6 inhibitors: A review on therapeutic implicationsMohd Yousuf, Manzar Alam, Anas Shamsi, et al.
International Journal of Biological Macromolecules|April 29, 2018
Implication of sulfonylurea derivatives as prospective inhibitors of human carbonic anhydrase IIDanish Idrees, Murtuza Hadianawala, Amarjyoti Das Mahapatra, et al.
ACS Omega|September 21, 2020
Design and Development of Small-Molecule Arylaldoxime/5-Nitroimidazole Hybrids as Potent Inhibitors of MARK4: A Promising Approach for Target-Based Cancer TherapyMudasir Nabi Peerzada, Parvez Khan, Nashrah Sharif Khan, et al.
Journal of Natural Products|July 26, 2019
Identification of α-Mangostin as a Potential Inhibitor of Microtubule Affinity Regulating Kinase 4Parvez Khan, Aarfa Queen, Taj Mohammad, et al.
Pageof 13

Showing results (41-50 of 128) with videos related to

Sort By:
Pageof 13
Contemporary Clinical Trials|January 10, 2023
Gender differences in first authorship of randomized controlled trials from IndiaBharat Rawlley, Afzal Parvez Khan, Shrey Chopra, et al.
Annals of African Medicine|November 29, 2025
Comparison of Ultrasound-assisted versus Landmark-guided Subarachnoid Block in Patients of Ankylosing Spondylitis Undergoing Total Hip Replacement: A Prospective Randomized TrialNeel Kamal Mishra, Rishabh Mishra, Prem Raj Singh, et al.
Molecular and Cellular Biochemistry|July 27, 2017
Evidence of vanillin binding to CAMKIV explains the anti-cancer mechanism in human hepatic carcinoma and neuroblastoma cellsHuma Naz, Mohd Tarique, Parvez Khan, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|July 29, 2019
Evaluation of ellagic acid as an inhibitor of sphingosine kinase 1: A targeted approach towards anticancer therapyPreeti Gupta, Taj Mohammad, Parvez Khan, et al.
Bone|July 19, 2016
Characterization of BMP signaling dependent osteogenesis using a BMP depletable avianized bone marrow stromal cell line (TVA-BMSC)Prem Swaroop Yadav, Mohd Parvez Khan, Paritosh Prashar, et al.
Molecular Pharmaceutics|July 25, 2018
Thienopyrimidine-Chalcone Hybrid Molecules Inhibit Fas-Activated Serine/Threonine Kinase: An Approach To Ameliorate Antiproliferation in Human Breast Cancer CellsNashrah Sharif Khan, Parvez Khan, Mohammad Fawad Ansari, et al.
International Journal of Biological Macromolecules|July 25, 2022
Structure-guided design and development of cyclin-dependent kinase 4/6 inhibitors: A review on therapeutic implicationsMohd Yousuf, Manzar Alam, Anas Shamsi, et al.
International Journal of Biological Macromolecules|April 29, 2018
Implication of sulfonylurea derivatives as prospective inhibitors of human carbonic anhydrase IIDanish Idrees, Murtuza Hadianawala, Amarjyoti Das Mahapatra, et al.
ACS Omega|September 21, 2020
Design and Development of Small-Molecule Arylaldoxime/5-Nitroimidazole Hybrids as Potent Inhibitors of MARK4: A Promising Approach for Target-Based Cancer TherapyMudasir Nabi Peerzada, Parvez Khan, Nashrah Sharif Khan, et al.
Journal of Natural Products|July 26, 2019
Identification of α-Mangostin as a Potential Inhibitor of Microtubule Affinity Regulating Kinase 4Parvez Khan, Aarfa Queen, Taj Mohammad, et al.
Pageof 13